Millions of books in English, Spanish and other languages. Free UK delivery 

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
Type
Physical Book
Publisher
Year
2016
Language
English
Pages
676
Format
Hardcover
ISBN13
9780128021736
Edition No.
1

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Michael S. Wolfe (Author) · Academic Press · Hardcover

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges - Michael S. Wolfe

New Book

£ 234.05

  • Condition: New
Origin: U.S.A. (Import costs included in the price)
It will be shipped from our warehouse between Wednesday, May 15 and Friday, May 31.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.

Synopsis "Developing Therapeutics for Alzheimer's Disease: Progress and Challenges"

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer’s disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the special challenges related to specific targets and approaches, while presenting a realistic, comprehensive and balanced view of drug discovery and development in this area. Written by international leaders in the field, the book assesses prospects for the emergence of effective agents and allows readers to better understand the challenges, failures, and future potential for research in Alzheimer’s disease. This book is a valuable resource to academic scientists carrying out translational research in Alzheimer’s disease, industrial scientists engaged in Alzheimer's drug discovery, executives in biopharmaceutical companies making strategic decisions regarding the direction of internal research and potential outside partnerships, and graduate-level students pursuing courses on Alzheimer's therapeutics.Provides a realistic but promising assessment of the potential of various therapeutic approaches to Alzheimer’s diseaseFocuses primarily on neuroprotective agents and cognitive enhancers, as well as approaches to targeting the amyloid B-peptide, tau and Apolipoprotein EDiscusses alternative approaches, preclinical and clinical development issues, related biomarkers and diagnostics, and prevention and nonpharmacological approaches

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Answer:
All books in our catalog are Original.
Answer:
The book is written in English.
Answer:
The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews